Philosophy of Care:I am dedicated to the early detection of cardiovascular disease and to the achievement of ideal cardiovascular health through lifestyle changes and medical therapy.
Plucinski DA, Scheltema K, Krusmark J, Panchyshyn N. A comparison of clopidogrel to ticlopidine therapy for the prevention of major cardiac events at thirty days and six months following coronary stent implantation. J Am Coll Cardiol 2000; 35 (Suppl A): 67.
Plucinski DA, Krusmark J, Obenchain R, Scheltema K, McCollam P. A naturalistic study of abciximab use in percutaneous intervention. Am J Cardiol 2000; 86 (Suppl 8A): 69 i.
Plucinski DA, Krusmark J, Scheltema K, McCollam P, Bala M. The effect of abciximab administration on the in hospital, 30 day, and 6 month outcomes of percutaneous coronary intervention for acute myocardial infarction. A report of the CVC.NMH PCI Registry. Circulation 2000; 102 (Suppl II):
Ribner HS, Plucinski DA, Hsieh AM, Bresnahan D, Molteni A, Askenazi J, Lesch M: Acute effects of digoxin on total systemic vascular resistance in congestive heart failure due to dilated cardiomyopathy: A hemodynamic hormonal study. Am J of Card 1985; 56:896-904.
Plucinski DA, Fishman SJ, Opravil M, Ganote C, Moran JM, Bulawa WF, Lesch M, Meyers S: Comparison of angiographic and pathologic examination of human coronary arteries. Circulation 1984; 70(Supp II):326(A).